» Authors » Marek Woynarowski

Marek Woynarowski

Explore the profile of Marek Woynarowski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 356
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Woynarowski M, Sapiejka E, Jozwiak M, Milczewska J, Zybert K, Krusinski A, et al.
Heliyon . 2024 May; 10(10):e31189. PMID: 38813168
It has been shown that macro-ALT/macro-AST cause false increase of ALT/AST activity in standard laboratory testing. This short communication presents a group of cystic fibrosis subjects who developed aminotranferases flare...
2.
Woynarowski M, Sapiejka E, Jozwiak M, Wierzbicka-Rucinska A
Clin Exp Hepatol . 2024 May; 9(4):405-409. PMID: 38774202
Aim Of The Study: The presence of macroenzymes may mimic treatment related hepatotoxicity. Material And Methods: We present a female subject who developed high alanine aminotransferase (ALT)/aspartate aminotransferase (AST) activity...
3.
Ricciuto A, Liu K, El-Matary W, Amin M, Amir A, Aumar M, et al.
Aliment Pharmacol Ther . 2024 Mar; 59(10):1236-1247. PMID: 38462727
Background: Data on oral vancomycin for primary sclerosing cholangitis (PSC)-associated inflammatory bowel disease (IBD) are limited. Aims: Using data from the Paediatric PSC Consortium, to examine the effect of vancomycin...
4.
Ledder O, Woynarowski M, Kaminska D, Lazowska-Przeorek I, Pieczarkowski S, Romano C, et al.
J Pediatr Gastroenterol Nutr . 2023 Jun; 77(3):401-406. PMID: 37276149
Objectives: Iatrogenic viscus perforation in pediatric gastrointestinal endoscopy (GIE) is a very rare, yet potentially life-threatening event. There are no evidence-based recommendations relating to immediate post-procedure follow-up to identify perforations...
5.
Mielus M, Sands D, Woynarowski M
Nutrition . 2022 Jul; 102:111725. PMID: 35816813
With increasing life expectancy of patients with cystic fibrosis (CF), gastrointestinal manifestations of the disease have been increasingly brought into focus. This was a systematic review of the PubMed database...
6.
Martinez M, Perito E, Valentino P, Mack C, Aumar M, Broderick A, et al.
Hepatology . 2021 May; 74(4):2047-2057. PMID: 34008252
Background And Aims: Recurrent primary sclerosing cholangitis (rPSC) following liver transplant (LT) has a negative impact on graft and patient survival; little is known about risk factors for rPSC or...
7.
Deneau M, Mack C, Perito E, Ricciuto A, Valentino P, Amin M, et al.
Hepatology . 2020 May; 73(3):1074-1087. PMID: 32464706
Background And Aims: Disease progression in children with primary sclerosing cholangitis (PSC) is variable. Prognostic and risk-stratification tools exist for adult-onset PSC, but not for children. We aimed to create...
8.
Sowinska A, Morsy Y, Czarnowska E, Oralewska B, Konopka E, Woynarowski M, et al.
Cells . 2020 Feb; 9(2). PMID: 32102433
Disruption of epithelial junctional complex (EJC), especially tight junctions (TJ), resulting in increased intestinal permeability, is supposed to activate the enhanced immune response to gluten and to induce the development...
9.
Deneau M, Valentino P, Mack C, Alqoaer K, Amin M, Amir A, et al.
J Pediatr Gastroenterol Nutr . 2019 Oct; 70(1):e12-e17. PMID: 31651664
Background: Natural history models for primary sclerosing cholangitis (PSC) are derived from adult patient data, but have never been validated in children. It is unclear how accurate such models are...
10.
Wozniak S, Pytrus T, Woynarowski M, Pula B, Domagala Z, Iwanczak B
Adv Clin Exp Med . 2019 Apr; 28(12):1627-1632. PMID: 31025556
Background: In children, colonoscopy is a safe procedure, although it is more difficult to perform in patients whose body mass index (BMI) is under 25. Objectives: The aim of the...